These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18431511)

  • 21. Circulating cytokines are associated with human islet graft function in type 1 diabetes.
    Pfleger C; Schloot NC; Brendel MD; Burkart V; Hogenkamp V; Bretzel RG; Jaeger C; Eckhard M
    Clin Immunol; 2011 Feb; 138(2):154-61. PubMed ID: 21094094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ingested interferon-alpha prevents allograft islet transplant rejection.
    Brod SA; Katz S; Phan T; Stepkowski S
    Transplantation; 2000 May; 69(10):2162-6. PubMed ID: 10852617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transplantation of co-aggregates of Sertoli cells and islet cells into liver without immunosuppression.
    Takemoto N; Liu X; Takii K; Teramura Y; Iwata H
    Transplantation; 2014 Feb; 97(3):287-93. PubMed ID: 24342973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JAK3 inhibitor-based immunosuppression in allogeneic islet transplantation in cynomolgus monkeys.
    Kim JM; Shin JS; Min BH; Kang SJ; Yoon IH; Chung H; Kim J; Hwang ES; Ha J; Park CG
    Islets; 2019; 11(5):119-128. PubMed ID: 31483188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune responses against islet allografts during tapering of immunosuppression--a pilot study in 5 subjects.
    Huurman VA; van der Torren CR; Gillard P; Hilbrands R; van der Meer-Prins EP; Duinkerken G; Gorus FK; Claas FH; Keymeulen B; Roelen DL; Pipeleers DG; Roep BO
    Clin Exp Immunol; 2012 Aug; 169(2):190-8. PubMed ID: 22774994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In situ protection against islet allograft rejection by CTLA4Ig transduction.
    Londrigan SL; Sutherland RM; Brady JL; Carrington EM; Cowan PJ; d'Apice AJ; O'Connell PJ; Zhan Y; Lew AM
    Transplantation; 2010 Nov; 90(9):951-7. PubMed ID: 20808263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bio-synthetic materials for immunomodulation of islet transplants.
    Foster GA; García AJ
    Adv Drug Deliv Rev; 2017 May; 114():266-271. PubMed ID: 28532691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
    Wong CP; Li L; Frelinger JA; Tisch R
    J Immunol; 2006 Feb; 176(3):1637-44. PubMed ID: 16424193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stromal cells as a means of controlling pathological T-cell responses in allogeneic islet transplantation.
    Reading JL; Sabbah S; Busch S; Tree TI
    Curr Opin Organ Transplant; 2013 Feb; 18(1):59-64. PubMed ID: 23222174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive PLGA TGF-β1 Microparticles Induce Polyclonal and Antigen-Specific Regulatory T Cells for Local Immunomodulation of Allogeneic Islet Transplants.
    Li Y; Frei AW; Labrada IM; Rong Y; Liang JP; Samojlik MM; Sun C; Barash S; Keselowsky BG; Bayer AL; Stabler CL
    Front Immunol; 2021; 12():653088. PubMed ID: 34122410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localized Immunomodulation with PD-L1 Results in Sustained Survival and Function of Allogeneic Islets without Chronic Immunosuppression.
    Batra L; Shrestha P; Zhao H; Woodward KB; Togay A; Tan M; Grimany-Nuno O; Malik MT; Coronel MM; García AJ; Shirwan H; Yolcu ES
    J Immunol; 2020 May; 204(10):2840-2851. PubMed ID: 32253240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimizing immunosuppression in islet xenotransplantation.
    Shin JS; Kim JS; Kim JM; Jang JY; Kim YH; Kim HJ; Park CG
    Immunotherapy; 2014; 6(4):419-30. PubMed ID: 24815782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vivo Costimulation Blockade-Induced Regulatory T Cells Demonstrate Dominant and Specific Tolerance to Porcine Islet Xenografts.
    Wu J; Hu M; Qian YW; Hawthorne WJ; Burns H; Liuwantara D; Alexander SI; Yi S; O'Connell PJ
    Transplantation; 2017 Jul; 101(7):1587-1599. PubMed ID: 27653300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coating human pancreatic islets with CD4(+)CD25(high)CD127(-) regulatory T cells as a novel approach for the local immunoprotection.
    Marek N; Krzystyniak A; Ergenc I; Cochet O; Misawa R; Wang LJ; Gołąb K; Wang X; Kilimnik G; Hara M; Kizilel S; Trzonkowski P; Millis JM; Witkowski P
    Ann Surg; 2011 Sep; 254(3):512-8; discussion 518-9. PubMed ID: 21865948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tregs and Mixed Chimerism as Approaches for Tolerance Induction in Islet Transplantation.
    Pathak S; Meyer EH
    Front Immunol; 2020; 11():612737. PubMed ID: 33658995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical islet transplantation at the University of Alberta--the Edmonton experience.
    Truong W; Lakey JR; Ryan EA; Shapiro AM
    Clin Transpl; 2005; ():153-72. PubMed ID: 17424733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical-grade multipotent adult progenitor cells durably control pathogenic T cell responses in human models of transplantation and autoimmunity.
    Reading JL; Yang JH; Sabbah S; Skowera A; Knight RR; Pinxteren J; Vaes B; Allsopp T; Ting AE; Busch S; Raber A; Deans R; Tree TI
    J Immunol; 2013 May; 190(9):4542-52. PubMed ID: 23547116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppression and pancreatic islet transplantation.
    Kneteman NM; Cattral MC; Warnock GL; Scharp DW; Jaspan JL; Rajotte RV
    Horm Metab Res Suppl; 1990; 25():193-9. PubMed ID: 2088967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of islet transplantation tolerance using donor specific transfusion and anti-CD154 monoclonal antibody.
    Rossini AA; Mordes JP; Markees TG; Phillips NE; Gordon EJ; Greiner DL
    Transplant Proc; 1999; 31(1-2):629-32. PubMed ID: 10083269
    [No Abstract]   [Full Text] [Related]  

  • 40. T-cell-directed immunosuppression allows prolonged survival of xenogeneic pig islets in monkeys.
    Jonker M; Rijkelijkhuizen JK; Haanstra KG; Kuhn EM; Ringers J; Bouwman E
    Transplant Proc; 2001; 33(1-2):726. PubMed ID: 11267041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.